Please login to the form below

Not currently logged in
Email:
Password:

Sanofi and Audion in hearing partnership

Sanofi has entered into a two-year research collaboration with the Audion Therapeutics to develop potential treatments for hearing loss

Sanofi has entered into a two-year research collaboration with the Audion Therapeutics to develop potential treatments for hearing loss through the optimisation of small molecules by using a regenerative medicine approach.

The research will use technology developed at the Massachusetts Eye and Ear Infirmary in the Eaton-Peabody Laboratory, a basic research facility dedicated to the study of hearing and deafness, by investigator and Audion co-founder Dr Albert Edge, who has strong expertise in stem cells and inner ear biology. Audion licensed Dr Edge's technology from Mass Eye and Ear. 

Under the terms of the agreement, Sanofi has an option to license technology rights from Audion related to research conducted under the collaboration.

<

Dr Elias Zerhouni, president of global R&D at Sanofi, said: "Our new relationship with Audion demonstrates our commitment to work with partners on conditions with unmet and growing medical needs, such as hearing loss.

"This collaboration is a multi-disciplinary approach with our internal Aging Therapeutic Strategic Unit and our Early-to-Candidate Unit working together to advance novel therapies in the field of otolaryngology using the most advanced technologies available to study cochlear biology," he added.

16th June 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wordbird

Wordbird is a healthcare communications agency with creative, compelling copy at its heart....

Latest intelligence

NHS regional footprints
What to expect from 2019...
Not another weight-loss ad
Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...
China’s clinical trial shake-up
As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...

Infographics